多重的集合:抗生素还是类固醇?
Philippe Raphael Dias1, Levin Bolt1, Christof Iking-Konert2
1Department of Internal Medicine, Stadtspital Zurich Triemli, Zurich, Switzerland.
Case reports in immunology
|February 2, 2024
概括
无菌综合征 (AAS) 是一种罕见的疾病,其特征是多重和炎症性肠病. 诊断需要排除感染,并使用皮质类固醇,阿纳金拉或因弗力西马布作为潜在的治疗方法.
科学领域:
- 皮肤病学 皮肤病学
- 类风湿病学 类风湿病学
- 胃肠病学 胃肠病学
背景情况:
- 无菌综合征 (AAS) 是一种罕见的医疗状况.
- 它在各种器官中呈现出多个,并与炎症性肠病有关.
研究的目的:
- 描述无菌综合征的特征和诊断挑战.
- 审查AAS目前的治疗策略.
- 强调在诊断AAS之前排除感染原因的重要性.
主要方法:
- 关于无菌综合征病例的文献综述.
- 对AAS的诊断标准的分析.
- 治疗方法的总结,包括皮质类固醇,anakinra和infliximab.
主要成果:
- AAS诊断依赖于排除多重和炎症性肠病患者的感染.
- 患有AAS的患者通常在血液动力学上稳定,尽管有严重的炎症.
- 对AAS的最佳治疗方案尚未确定.
结论:
- 无菌综合征是一种排除的诊断.
- 皮质类固醇是急性AAS的主要治疗方法.
- 阿纳金拉和因弗利西马布是AAS的潜在二线疗法.
更多相关视频
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
224
05:18Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
1.4K
相关概念视频
Tonsillitis II: Management
111
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
111
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Antibiotic Selection
53.6K
Overview
53.6K
Pneumonia IV: Management
329
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
329
Drugs for Treatment of Ulcerative Colitis in IBD
141
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
